S-Quatre Corporation
VC Fund
Tokyo, Japan
S-Quatre Corporation is a VC fund in Tokyo focused on Health Care and Medical. S-Quatre is a biomedicine company that provides healthcare solutions as well as the creation of new medications and therapeutics.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries S-Quatre Corporation invests in
Stages S-Quatre Corporation invests in
Countries S-Quatre Corporation invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 2 (100%)
- Medical 1 (50%)
- Biotechnology 1 (50%)
- Manufacturing 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Pre-Seed 1 (50%)
- Corporate Round 1 (50%)
Country
- Japan 1 (50%)
- United Kingdom 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Masaharu Tani
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
Masayuki Kawakami
Corporate Officer, CTO
|
Corporate Officer, CTO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Alfenax Biologics
|
Alfenax Biologics is a Japanese joint venture established by Mycenax Biotech, Alfresa Holdings, Kidswell Bio Corporation, and Chiome Bioscience to build a dedicated biologics manufacturing base in Japan. | Corporate Round / Mar 09, 2026 | |
LYMPHOGENiX
|
LYMPHOGENiX aspires to be a global leader in lymphatic science, addressing unmet needs in both human and animal health. Our purpose is to unleash the lymphatic system's latent potential to tackle real-world health concerns. | $339.6K / Pre-Seed / Jul 08, 2025 |
Co-Investors
Alfresa Holdings
1 deal together
Chiome Bioscience
1 deal together
Glocalink
1 deal together
Keio Innovation Initiative
1 deal together
Mycenax Biotech
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does S-Quatre Corporation invest in?
S-Quatre Corporation invests primarily in Health Care, Medical and Biotechnology startups, most often at Pre-Seed and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact S-Quatre Corporation?
Public channels for S-Quatre Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at S-Quatre Corporation?
The team at S-Quatre Corporation includes Masaharu Tani (President & CEO) and Masayuki Kawakami (Corporate Officer, CTO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
